Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative

Objective Prompted by an alarmingly low screening rate for metabolic bone disease of prematurity (MBDP), we aimed to increase MBDP screening with serum calcium, phosphorous, and alkaline phosphatase at four to six weeks of life in infants born at

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of perinatology 2024-09, Vol.44 (9), p.1369-1376
Hauptverfasser:	Creed, Priya V., Huff, Katie A., Beard, Kate, DiMeglio, Linda A., Stefanescu, Beatrice M.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/163/2743/316 692/700/1720 Alkaline phosphatase Alkaline Phosphatase - blood Birth weight Bone diseases Bone Diseases, Metabolic - diagnosis Bone Diseases, Metabolic - prevention & control Calcium - administration & dosage Calcium - blood Comorbidity Dietary minerals Dietary Supplements Dietitians Enteral Nutrition Female Gestational age Humans Infant, Newborn Infant, Premature Infant, Premature, Diseases - diagnosis Infant, Premature, Diseases - prevention & control Infant, Very Low Birth Weight Infants Interdisciplinary aspects Intervention Male Medicine Medicine & Public Health Metabolism Mineralization Multidisciplinary teams Neonatal Screening - methods Neonates Newborn babies Nutrition Parenteral nutrition Pediatric Surgery Pediatrics Phosphatase Phosphorus - blood Premature babies Premature birth Quality control Quality Improvement Quality Improvement Article Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective Prompted by an alarmingly low screening rate for metabolic bone disease of prematurity (MBDP), we aimed to increase MBDP screening with serum calcium, phosphorous, and alkaline phosphatase at four to six weeks of life in infants born at
ISSN:	0743-8346 1476-5543 1476-5543
DOI:	10.1038/s41372-024-01892-9